HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

BET 1: Intravenous tranexamic acid in the treatment of acute epistaxis.

Abstract
A short-cut review was carried out to establish whether intravenous tranexamic acid is beneficial in managing acute epistaxis. Seven papers were found in Medline, Embase and the Cochrane Library using the reported searches, but none presented any evidence to answer the clinical question. It is concluded that there is no evidence to support or refute the use of intravenous tranexamic acid in acute epistaxis and that local advice should be followed.
AuthorsHannah Fox, Fiona Hunter
JournalEmergency medicine journal : EMJ (Emerg Med J) Vol. 32 Issue 12 Pg. 969-70 (Dec 2015) ISSN: 1472-0213 [Electronic] England
PMID26598634 (Publication Type: Journal Article, Review)
CopyrightPublished by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/
Chemical References
  • Antifibrinolytic Agents
  • Tranexamic Acid
Topics
  • Acute Disease
  • Administration, Intravenous
  • Antifibrinolytic Agents (administration & dosage)
  • Epistaxis (drug therapy)
  • Evidence-Based Emergency Medicine
  • Humans
  • Tranexamic Acid (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: